Characterizing the immunomodulatory effects of the antioxidant TEMPOL in a model of multiple sclerosis

Characterizing the immunomodulatory effects of the antioxidant TEMPOL in a model of multiple sclerosis

Show other versions (1)

Bibliographic Details
Main Author:	Neil, Sarah Elizabeth
Language:	English
Published:	University of British Columbia 2013
Online Access:	http://hdl.handle.net/2429/45335

Similar Items

Characterizing the immunomodulatory effects of the antioxidant TEMPOL in a model of multiple sclerosis
by: Neil, Sarah Elizabeth
Published: (2013)

Immunomodulatory Effects of Exercise in Experimental Multiple Sclerosis
by: Antonietta Gentile, et al.
Published: (2019-09-01)

Immunomodulatory treatments for relapsing–remitting multiple sclerosis
by: Fritz Leutmezer
Published: (2017-01-01)

The Effects of the Synthetic Antioxidant, Tempol, on Serum Glucose and Lipid Profile of Diabetic and Non-Diabetic Rats
by: Shahidi, et al.
Published: (2016-01-01)

The longitudinal immunomodulatory effect of simvastatins in secondary progressive multiple sclerosis
by: Schuerer, N. S.
Published: (2012)

Protective Effect of Tempol against Cisplatin-Induced Ototoxicity
by: Cha Kyung Youn, et al.
Published: (2016-11-01)

The use of immunomodulatory therapy in pregnant patients with multiple sclerosis
by: Julia Rudnicka-Czerwiec, et al.
Published: (2018-11-01)

Tempol differently affects cellular redox changes and antioxidant enzymes in various lung-related cells
by: Woo Hyun Park
Published: (2021-07-01)

Immunomodulatory and anti-inflammatory effects of probiotics in multiple sclerosis: a systematic review
by: Mohammad Morshedi, et al.
Published: (2019-11-01)

Systemic Administration of Tempol Attenuates the Cardiorespiratory Depressant Effects of Fentanyl
by: Santhosh Baby, et al.
Published: (2021-06-01)

Tempol treatment reduces anxiety-like behaviors induced by multiple anxiogenic drugs in rats.
by: Gaurav Patki, et al.
Published: (2015-01-01)

Proposals to improve adherence to immunomodulatory therapies in patients with multiple sclerosis
by: E. Arroyo, et al.
Published: (2010-01-01)

Immunomodulatory and Anti-Inflammatory Effects of Scrophularia megalantha Ethanol Extract on an Experimental Model of Multiple Sclerosis
by: Abbas Azadmehr*, et al.
Published: (2018-01-01)

Developmental Hazard of Environmentally Persistent Free Radicals and Protective Effect of TEMPOL in Zebrafish Model
by: Xia Guan, et al.
Published: (2021-01-01)

Tempol treatment shows phenotype improvement in mdx mice.
by: Túlio de Almeida Hermes, et al.
Published: (2019-01-01)

Synergism in hyperhomocysteinemia and diabetes: role of PPAR gamma and tempol
by: Mishra Paras K, et al.
Published: (2010-09-01)

Restoration of Endothelial Function in Pparα−/− Mice by Tempol
by: Neerupma Silswal, et al.
Published: (2015-01-01)

Tempol e renoprotetor na nefropatia diabetica experimental
by: Peixoto, Elisa Bouçada Mauro Inacio
Published: (2010)

The Effects of Tempol on Cyclophosphamide-Induced Oxidative Stress in Rat Micturition Reflexes
by: Eric J. Gonzalez, et al.
Published: (2015-01-01)

Classical immunomodulatory therapy in multiple sclerosis: how it acts, how it works
by: Amélia Mendes, et al.
Published: (2011-06-01)

Beneficial Effect of Tempol, a Membrane-Permeable Radical Scavenger, on Inflammation and Osteoarthritis in In Vitro Models
by: Giovanna Calabrese, et al.
Published: (2021-02-01)

TEMPOL increases NAD+ and improves redox imbalance in obese mice
by: Mayumi Yamato, et al.
Published: (2016-08-01)

Stable redox-cycling nitroxide Tempol inhibits NET formation
by: Ava eHosseinzadeh, et al.
Published: (2012-12-01)

Tempol Attenuates Neuropathic Pain by Inhibiting Nitric Oxide Production
by: Donglin Jia, et al.
Published: (2019-01-01)

Tempol, an intracellular antioxidant, inhibits tissue factor expression, attenuates dendritic cell function, and is partially protective in a murine model of cerebral malaria.
by: Ivo M B Francischetti, et al.
Published: (2014-01-01)

In vitro characterization and in vivo toxicity, antioxidant and immunomodulatory effect of fermented foods; Xeniji™
by: Noraisyah Zulkawi, et al.
Published: (2017-06-01)

Immunomodulatory, anti-inflammatory, and antioxidant effects of curcumin
by: Nadia Boroumand, et al.
Published: (2018-10-01)

Renal Protection of In Vivo Administration of Tempol in Streptozotocin-Induced Diabetic Rats
by: Jiajie Luan, et al.
Published: (2012-01-01)

Inflammation induced by increased frequency of intermittent hypoxia is attenuated by tempol administration
by: J. Zhang, et al.
Published: (2015-12-01)

Lipoic acid, but not tempol, preserves vascular compliance and decreases medial calcification in a model of elastocalcinosis
by: E. Bassi, et al.
Published: (2014-02-01)

The Immunomodulatory and Neuroprotective Effects of Mesenchymal Stem Cells (MSCs) in Experimental Autoimmune Encephalomyelitis (EAE): A Model of Multiple Sclerosis (MS)
by: Mohamed H. Abumaree, et al.
Published: (2012-07-01)

Neuroprotective effect of S-allyl cysteine on an experimental model of multiple sclerosis: Antioxidant effects
by: B.M. Escribano, et al.
Published: (2018-03-01)

Understanding Progressive Multifocal Leukoencephalopathy Risk in Multiple Sclerosis Patients Treated with Immunomodulatory Therapies: A Bird’s Eye View
by: Elizabeth A. Mills, et al.
Published: (2018-02-01)

A comparative study of melatonin and immunomodulatory therapy with interferon beta and glatiramer acetate in a mouse model of multiple sclerosis
by: E.J. Ramos González, et al.
Published: (2021-05-01)

The Paradoxical Leishmanicidal Effects of Superoxide Dismutase (SOD)-Mimetic Tempol in Leishmania braziliensis Infection in vitro
by: Laíse B. Oliveira, et al.
Published: (2019-06-01)

Stable Redox-Cycling Nitroxide Tempol Has Antifungal and Immune-Modulatory Properties
by: Ava Hosseinzadeh, et al.
Published: (2019-08-01)

Tempol Supplementation Restores Diaphragm Force and Metabolic Enzyme Activities in mdx Mice
by: David P. Burns, et al.
Published: (2017-12-01)

Inibição da atividade catalítica da proteína dissulfeto isomerase por tempol
by: SANTOS, Gérsika Bitencourt
Published: (2015)

Prevalence and factors leading to unemployment in MS (multiple sclerosis) patients undergoing immunomodulatory treatment in Poland.
by: Dorota Koziarska, et al.
Published: (2018-01-01)

Immunomodulatory Effect of Pregnancy on Leukocyte Populations in Patients With Multiple Sclerosis: A Comparison of Peripheral Blood and Decidual Placental Tissue
by: Michela Spadaro, et al.
Published: (2019-08-01)